{"entity":{"type":"insider","cik":"0001600946","url":"/insider/0001600946","json_url":"/insider/0001600946.json","name":"Plassche Douglas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2015-04-28","last":"2025-10-03","span_basis":"filed_date"},"name_variants":[{"name":"Plassche Douglas","source":"filing","n_filings":4,"first_seen":"2015-04-28","last_seen":"2025-10-03"}],"transactions":[{"id":5090656,"accession":"0001493152-25-016979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-016979","line_url":"/filing/0001493152-25-016979#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001600946","owner_name":"Plassche Douglas","owner_display_name":"Plassche Douglas","owner_url":"/insider/0001600946","role":"Officer (EVP Operations)","role_mark":"O","role_mark_label":"Officer (EVP Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Operations","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800000.0,"shares_display":"800,000","price_per_share":0.624,"price_display":"0.62","price_state":"stated","total_value":499200.0,"total_display":"499,200.00","total_whole":"499,200","shares_owned_after":3500000.0,"shares_owned_after_display":"3,500,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4353716,"accession":"0001641172-25-018593","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-018593","line_url":"/filing/0001641172-25-018593#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001600946","owner_name":"Plassche Douglas","owner_display_name":"Plassche Douglas","owner_url":"/insider/0001600946","role":"Officer (EVP Operations)","role_mark":"O","role_mark_label":"Officer (EVP Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Operations","security_title":"Stock Options (right to buy)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":0.579,"price_display":"0.58","price_state":"stated","total_value":115800.0,"total_display":"115,800.00","total_whole":"115,800","shares_owned_after":2300000.0,"shares_owned_after_display":"2,300,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-08","filed_date":"2025-07-10","scope":"insider"},{"id":3183651,"accession":"0001493152-24-042726","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-24-042726","line_url":"/filing/0001493152-24-042726#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001600946","owner_name":"Plassche Douglas","owner_display_name":"Plassche Douglas","owner_url":"/insider/0001600946","role":"Officer (SVP of Operations)","role_mark":"O","role_mark_label":"Officer (SVP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":333932.0,"shares_display":"333,932","price_per_share":0.51,"price_display":"0.51","price_state":"stated","total_value":170305.32,"total_display":"170,305.32","total_whole":"170,305","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-24","filed_date":"2024-10-28","scope":"insider"},{"id":3183647,"accession":"0001493152-24-042726","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-042726","line_url":"/filing/0001493152-24-042726#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001600946","owner_name":"Plassche Douglas","owner_display_name":"Plassche Douglas","owner_url":"/insider/0001600946","role":"Officer (SVP of Operations)","role_mark":"O","role_mark_label":"Officer (SVP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800000.0,"shares_display":"800,000","price_per_share":0.49,"price_display":"0.49","price_state":"stated","total_value":392000.0,"total_display":"392,000.00","total_whole":"392,000","shares_owned_after":333932.0,"shares_owned_after_display":"333,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-23","filed_date":"2024-10-28","scope":"insider"},{"id":8198372,"accession":"0001053369-15-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-15-000026","line_url":"/filing/0001053369-15-000026#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001600946","owner_name":"Plassche Douglas","owner_display_name":"Plassche Douglas","owner_url":"/insider/0001600946","role":"Officer (Executive VP of Operations)","role_mark":"O","role_mark_label":"Officer (Executive VP of Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP of Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85530.0,"shares_display":"85,530","price_per_share":0.2358,"price_display":"0.24","price_state":"stated","total_value":20167.974,"total_display":"20,167.97","total_whole":"20,168","shares_owned_after":73094.0,"shares_owned_after_display":"73,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-27","filed_date":"2015-04-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001053369","name":"ELITE PHARMACEUTICALS INC /NV/","url":"/issuer/0001053369","role":"Officer (EVP Operations)","n_filings":4,"first_seen":"2015-04-28","last_seen":"2025-10-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001600946","retrieved_at":"2026-08-27T04:03:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}